Dosing & Uses
Dosage Forms & Strengths
bacitracin/hydrocortisone/neomycin/polymyxin
topical ointment
- (400 units/10mg/35mg/4000 units)/1gram
Steroid Responsive Dermatoses with Infection
Apply thin layer of cream topically to affected area(s) BID-QID for up to 7 days
Use sparingly
Adverse Effects
Frequency Not Defined
Skin sensitization
Burning
Itching
Irritation
Dryness
Folliculitis
Hypertrichosis
Acneiform eruptions
Hypopigmentation
Perioral dermatitis
Allergic contact dermatitis
Maceration of the skin
Secondary infection
Skin atrophy
Striae
Miliaria
Warnings
Contraindications
Hypersensitivity
Cautions
For external use only
Pregnancy & Lactation
Pregnancy
There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids; corticosteroids generally teratogenic in laboratory animals when administered systemically at relatively low dosage levels; topical corticosteroids should be used during pregnancy only if potential benefits justify potential risk to fetus; should not be used extensively on pregnant patients, in large amounts, or for prolonged periods of time
Lactation
Not know whether topical administration could result in sufficient systemic absorption to produce detectable quantities in breast milk; systemically administered corticosteroids are secreted into breast milk in quantities not likely to have deleterious effect on infant; nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Pharmacology
Mechanism of Action
Bacitracin: Inhibits bacterial cell wall synthesis, by preventing the incorporation of mucopeptides into the growing cell wall
Hydrocortisone: Antipruritic/anti-inflammatory action; mild-to-medium corticosteroid potency
Neomycin: Bacteriostatic when administered topically
Polymyxin: Bactericidal; causes leakage of bacterial membrane by binding to phospholipids